We used two different SOD1 inhibitors, 4,5-dichloro-2-m-tolyl pyridazin-3(2H)-one (also known as lung cancer screen-1 [LCS-1]) and Bis-choline tetrathiomolybdate (ATN-224), which work by different mechanisms. The gene discussed is SOD1; the disease is lung carcinoma.